Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

NURO 1.72 -0.01 (-0.58%)
price chart
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
Form SC 13G/A NeuroMetrix, Inc. Filed by: SABBY MANAGEMENT, LLC
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO),, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
Related articles »  
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
FDA clears NeuroMetrix wearable tech  Boston Globe
With consumer product, ​NeuroMetrix CEO says he'll need to open a new ...  Boston Business Journal (blog)
Related articles »  
Sabby Management Buys 3 Biotech Stocks
Traders may want to take note of holdings disclosed by Sabby Management LLC to the SEC on Thursday. The firm reported 9.99 percent ownership stakes in the following biotech companies: Neurometrix Inc (NASDAQ: NURO) is a medical device company ...
Friday Hot Alert: New Source Energy Partners L.P. (NSLP), NeuroMetrix Inc ...
NeuroMetrix Inc. (NURO) of the Medical Instruments & Supplies sector closed out the day yesterday at $1.73, a loss of 0.00% and return on investment of -101.40% trading at a volume of 18,151 shares.
Short Interest of Neurometrix Inc Drops by -6%
Neurometrix Inc (NASDAQ:NURO) stated loss of 15,739 shares or 6% in the short interest. The short interest registered from 262,770 on December 15,2014 to 247,031 on December 31,2014.
The Future Of NeuroMetrix
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so.
Related articles »  
NeuroMetrix Is Better Positioned After Share Raise
Yesterday morning, NeuroMetrix (NASDAQ:NURO) announced that the company was able to raise more than $10,000,000 by offering 10,500,000 shares at $1 per share, plus warrants.
Related articles »